MarketBeat Instant News Alerts 2 hours agoARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock Has Consensus Price Target of $25.00MarketBeatARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and fouNASDAQ:SPRYRead ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock Has Consensus Price Target of $25.002 hours agoPrelude Therapeutics Incorporated (NASDAQ:PRLD) Stock Rated "Moderate Buy" by Sell-Side AnalystsMarketBeatShares of Prelude Therapeutics Incorporated (NASDAQ:PRLD - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has NASDAQ:PRLDRead Prelude Therapeutics Incorporated (NASDAQ:PRLD) Stock Rated "Moderate Buy" by Sell-Side Analysts2 hours agoAnavex Life Sciences Corp. (NASDAQ:AVXL) Stock Now Rated "Hold" by Sell-Side AnalystsMarketBeatAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) has been assigned an average rating of "Hold" from the five brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and NASDAQ:AVXLRead Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Now Rated "Hold" by Sell-Side Analysts2 hours agoReal Matters Inc. (TSE:REAL) Stock Has Consensus Target Price of C$7.43MarketBeatReal Matters Inc. (TSE:REAL - Get Free Report) has earned an average rating of "Moderate Buy" from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendatioTSE:REALRead Real Matters Inc. (TSE:REAL) Stock Has Consensus Target Price of C$7.432 hours agoAvalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated "Moderate Buy" by Wall Street AnalystsMarketBeatAvalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold reNASDAQ:AVLNRead Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated "Moderate Buy" by Wall Street Analysts2 hours agoHemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of "Moderate Buy" from AnalystsMarketBeatHemab Therapeutics Holdings, Inc. (NASDAQ:COAG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommenNASDAQ:COAGRead Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of "Moderate Buy" from Analysts Trending News1Aurora Innovation (NASDAQ:AUR) Shares Down 6.7% - Here's Why2Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage3Intel (NASDAQ:INTC) Shares Down 5.7% - Here's Why4QuantumScape (NYSE:QS) Shares Down 6.4% - Here's What Happened5USA Rare Earth (NASDAQ:USAR) Stock Price Down 5% - Here's What Happened6Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Buy by Sanford C. Bernstein7Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why8Oracle (NYSE:ORCL) Shares Down 3.3% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoSol-Gel Technologies Ltd. (NASDAQ:SLGL) Stock Now Rated "Moderate Buy" by Sell-Side AnalystsMarketBeatNASDAQ:SLGLRead Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Stock Now Rated "Moderate Buy" by Sell-Side Analysts2 hours agoStewart Information Services Corporation (NYSE:STC) Stock Now Rated "Moderate Buy" by Wall Street AnalystsMarketBeatNYSE:STCRead Stewart Information Services Corporation (NYSE:STC) Stock Now Rated "Moderate Buy" by Wall Street Analysts2 hours agoAlliance Laundry Holdings Inc. (NYSE:ALH) Stock Has Average Price Target of $31.20MarketBeatNYSE:ALHRead Alliance Laundry Holdings Inc. (NYSE:ALH) Stock Has Average Price Target of $31.202 hours agoBritish American Tobacco p.l.c. (LON:BATS) Stock Rated "Moderate Buy" by Wall Street BrokeragesMarketBeatLON:BATSRead British American Tobacco p.l.c. (LON:BATS) Stock Rated "Moderate Buy" by Wall Street Brokerages2 hours agoATS Co. (TSE:ATS) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatTSE:ATSRead ATS Co. (TSE:ATS) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoThe Andersons, Inc. (NASDAQ:ANDE) Stock Has Consensus Target Price of $95.00 According to BrokeragesMarketBeatNASDAQ:ANDERead The Andersons, Inc. (NASDAQ:ANDE) Stock Has Consensus Target Price of $95.00 According to Brokerages2 hours agoACM Research, Inc. (NASDAQ:ACMR) Stock Has Consensus Price Target of $122.75MarketBeatNASDAQ:ACMRRead ACM Research, Inc. (NASDAQ:ACMR) Stock Has Consensus Price Target of $122.752 hours agoJOYY Inc. Sponsored ADR (NASDAQ:JOYY) Stock Now Rated "Moderate Buy" by Sell-Side AnalystsMarketBeatNASDAQ:JOYYRead JOYY Inc. Sponsored ADR (NASDAQ:JOYY) Stock Now Rated "Moderate Buy" by Sell-Side Analysts2 hours agoAMC Networks Inc. (NASDAQ:AMCX) Stock Rated "Strong Sell" by Sell-Side AnalystsMarketBeatNASDAQ:AMCXRead AMC Networks Inc. (NASDAQ:AMCX) Stock Rated "Strong Sell" by Sell-Side Analysts2 hours agoEvolv Technologies Holdings, Inc. (NASDAQ:EVLV) Stock Has Consensus Target Price of $9.81 According to AnalystsMarketBeatNASDAQ:EVLVRead Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Stock Has Consensus Target Price of $9.81 According to Analysts2 hours agoWhat is Zacks Research's Estimate for O-I Glass Q3 Earnings?MarketBeatNYSE:OIRead What is Zacks Research's Estimate for O-I Glass Q3 Earnings?2 hours agoMurphy USA Stock Earnings Estimates Lifted by Zacks ResearchMarketBeatNYSE:MUSARead Murphy USA Stock Earnings Estimates Lifted by Zacks Research2 hours agoResearch Analysts Offer Predictions for WTW Q2 EarningsMarketBeatNASDAQ:WTWRead Research Analysts Offer Predictions for WTW Q2 Earnings2 hours agoScotiabank Research Analysts Cut Earnings Estimates for PAASMarketBeatNYSE:PAASRead Scotiabank Research Analysts Cut Earnings Estimates for PAAS2 hours agoGreif Stock Earnings Estimates Decreased by Zacks ResearchMarketBeatNYSE:GEFRead Greif Stock Earnings Estimates Decreased by Zacks Research2 hours agoZacks Research Brokers Boost Earnings Estimates for OvintivMarketBeatNYSE:OVVRead Zacks Research Brokers Boost Earnings Estimates for Ovintiv2 hours agoZacks Research Cuts Earnings Estimates for Bank of HawaiiMarketBeatNYSE:BOHRead Zacks Research Cuts Earnings Estimates for Bank of Hawaii2 hours agoZacks Research Has Optimistic Opinion of Humana Q3 EarningsMarketBeatNYSE:HUMRead Zacks Research Has Optimistic Opinion of Humana Q3 Earnings2 hours agoHC Wainwright Brokers Boost Earnings Estimates for IOVAMarketBeatNASDAQ:IOVARead HC Wainwright Brokers Boost Earnings Estimates for IOVA2 hours agoJLL Stock Gets Increased EPS Estimate from Zacks ResearchMarketBeatNYSE:JLLRead JLL Stock Gets Increased EPS Estimate from Zacks Research2 hours agoZacks Research Has Optimistic Opinion of MTDR Q3 EarningsMarketBeatNYSE:MTDRRead Zacks Research Has Optimistic Opinion of MTDR Q3 Earnings2 hours agoAnalysts Issue Forecasts for Pharming Group Q3 EarningsMarketBeatNASDAQ:PHARRead Analysts Issue Forecasts for Pharming Group Q3 Earnings2 hours agoOvintiv Stock Earnings Estimates Increased by Zacks ResearchMarketBeatTSE:OVVRead Ovintiv Stock Earnings Estimates Increased by Zacks Research2 hours agoHC Wainwright Issues Optimistic Forecast for UNCY EarningsMarketBeatNASDAQ:UNCYRead HC Wainwright Issues Optimistic Forecast for UNCY Earnings Featured Articles and OffersHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of RisksBy Jessica Mitacek | September 24, 2026The end may be near for these iconic stocksFrom Chaikin Analytics (Ad)Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-OutBy Thomas Hughes | September 29, 2026The Case for Buying High-Yield General Mills Just StrengthenedBy Thomas Hughes | September 24, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 160 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
